Methyl-gag, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for non-hodgkin's lymphomas: A Swedish national prospective study

Acta Oncologica

Volumn 35, Issue 2, 1996, Pages 165-170

  Enblad, Gunilla ^a   Hagberg, Has ^a   Glimelius, Bengt ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; MITOGUAZONE;

ADULT; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; SWEDEN;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; ETOPOSIDE; FEMALE; HUMANS; IFOSFAMIDE; LYMPHOMA, NON-HODGKIN; MALE; METHOTREXATE; MIDDLE AGED; MITOGUAZONE; PROSPECTIVE STUDIES; SALVAGE THERAPY; SWEDEN; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0029885339     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869609098497     Document Type: Article

References (14)

1. Cabanillas F, Hagemeister FB, McLaughlin P, et al. Results of MIME salvage regimen for recurrent of refractory lymphoma. J Clin Oncol 1987; 5: 407-12.
2. Enblad G, Glimelius B, Hagberg H, Lindemalm C. Methyl-GAG, ifosfamide, metotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease and non-Hodgkin's lymphoma. Acta Oncol 1990; 29: 297-301.
3. Gugliemi C, Chauvin F, Hagenbeek A, et al. The Parma international randomized prospective study in relapsed non-Hodgkin lymphoma - Second interim analysis of 172 patients and update. Fifth International Conference on Malignant Lymphomas, June, 9-12, 1993, Lugano, Switzerland.
4. Gérard-Marchant R, Hamlin I, Lennert K, Rilke F, Standfield AG, van Unnik JAM. Classification of non-Hodgkin's lymphomas. Lancet 1974; 2: 406-8.
5. Glimelius B, Hagberg H, Sundström C. Morphological classification of non-Hodgkin malignant lymphoma. Scand J Haematol 1983; 30: 13-24.
6. Buzzoni R, Colleoni M, Bajetta E, Nolè P, De Palma CA, de Braud F. Effective salvage chemotherapy in relapsed or refractory non-Hodgkin's lymphoma. Ann Oncol 1993; 4: 251-3.
7. Haim N, Rosenblatt E, Wollner M, Ben-Shahar M, Epelbaum R, Robinson E. Salvage therapy for non-Hodgkin's lymphoma with a combination of dexamethasone, etoposide, ifosfamide, and cisplatin. Cancer Chemother Pharmacol 1992; 30: 243-4.
8. Nowroussian MR, Anders CH, Niederle N, et al. Etoposide, ifosfamide, and methotrexate with or without bleomycin in refractory or recurrent lymphomas. Ann Oncol 1991; 2 (Suppl 1): 25-30.
9. Goss PE, Shepherd FA, Scott JG, et al. Dexamethasone/ifosfamide/cisplatin/etoposide (DICE) as therapy for patients with advanced refractory non-Hodgkin's lymphomas: Preliminary report on a phase II study. Ann Oncol 1991; 2 (Suppl 1): 43-6.
10. Wilson WH, Bryant G, Bates S, et al. EPOCH chemotherapy: Toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphomas. J. Clin Oncol 1993; 11: 1573-82.
11. Case DC, Gerber MC, Gams RA, et al. Phase II study of intravenous idarubicin in unfavourable non-Hodgkin's lymphoma. Cancer Res 1992; 52: 3871-4.
12. Von Hoff DD. MGBG: Teaching and old drug new tricks. Ann Oncol 1994; 5: 487-93.
13. Dorigo A, Mansberg R, Kwan YL. Lomustine, etoposide, methotrexate and prednisone (LEMP) therapy for relapsed and refractory non-Hodgkin's lymphoma. Eur J Haematol 1993; 50: 37-40.
14. Straneo M, Gianni L. New active drugs in the treatment of lymphomas. Cur Opin Oncol 1994; 6: 480-8.